Last reviewed · How we verify
Norcaine (BENZOCAINE)
Norcaine (generic name: BENZOCAINE) is a Standardized Chemical Allergen [EPC] drug. It is currently FDA-approved for Cough, Itching of skin, Local anesthesia.
Norcaine, also known as benzocaine, is a small molecule standardized chemical allergen that targets the sodium channel protein type 5 subunit alpha. It is used to treat various conditions including cough, skin irritation, local anesthesia, and minor skin wound pain. The commercial status of Norcaine is not explicitly stated, but it is likely available as a generic medication. Key safety considerations include potential allergic reactions and interactions with other medications. As a local anesthetic, Norcaine works by blocking pain signals to the brain.
At a glance
| Generic name | BENZOCAINE |
|---|---|
| Drug class | Standardized Chemical Allergen [EPC] |
| Target | Sodium channel protein type 5 subunit alpha |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Cough
- Itching of skin
- Local anesthesia
- Minor Skin Wound Pain
- Mouth Irritation
- Prevent Minor Bacterial Skin Infection
- Skin irritation
- Sore throat symptom
- Suppression of the Gag Reflex
- Tinea Infections
- Tinea corporis
- Tinea pedis
Common side effects
Key clinical trials
- Manipulating Exercise Intensity and Affective Responses for Cardiac Rehabilitation Program Acute Coronary Syndrome Patients (NA)
- Running Environments on Physiological Responses, Emotion, Motivation, and Attention (NA)
- IASTM and Vibration Effects on Pain, Functionality, and Kinesiophobia in Lumbar Disc Herniation (NA)
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Impact of Sugammadex Versus Neostigmine on Early Postoperative Pulmonary Function (NA)
- Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke (NA)
- SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Norcaine CI brief — competitive landscape report
- Norcaine updates RSS · CI watch RSS
Frequently asked questions about Norcaine
What is Norcaine?
What is Norcaine used for?
What is the generic name of Norcaine?
What drug class is Norcaine in?
What development phase is Norcaine in?
What does Norcaine target?
Related
- Drug class: All Standardized Chemical Allergen [EPC] drugs
- Target: All drugs targeting Sodium channel protein type 5 subunit alpha
- Therapeutic area: All drugs in Metabolic
- Indication: Drugs for Cough
- Indication: Drugs for Itching of skin
- Indication: Drugs for Local anesthesia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing